tert-Butyl 4-(3-o-tolylureido)piperidine-1-carboxylate, 95.0%, 1g

Methyl 2-bromoquinoline-4-carboxylate, 97%, 250mg

Benzoic acid, 5-[bis[(2-hydroxyphenyl)methyl]amino]-2-hydroxy-, 98%, 250mg

tert-Butyl 3-(2,4-difluorophenyl)-3-hydroxyazetidine-1-carboxylate, 98%, 1g

(S)-2-(Aminomethyl)-3-methylbutanoic acid hydrochloride, 95.0%, 1g

Cyclohexane, ROTIPURAN®, min. 99.5%, pa, ACS, ISO, 2.5 l, glass packaging

Phenol, 4-[2-[[2-benzo[b]thien-3-yl-9-(1-methylethyl)-9H-purin-6-yl]amino]ethyl]-, 97%, 50mg

Dibromofluorescein (contains Mono-, Tri- and Tetra-)5g

Separating funnel, conical with PTFE tap 60 ml

(S)-1-Benzhydryl-2-methylazetidine hydrochloride, 98%, 100mg

Narrow neck bottle with flap closure, 500 ml, 10 Piece(s)

(S)-2-((tert-Butoxycarbonyl)amino)-3-(3,4-dihydroxyphenyl)propanoic acid, 97%, 5g

(3H-Imidazo[4,5-b]pyridin-5-yl)methanol, 95.0%, 1g